New avenues for anti-epileptic drug discovery and development

W Löscher, H Klitgaard, RE Twyman… - Nature reviews drug …, 2013 - nature.com
Despite the introduction of over 15 third-generation anti-epileptic drugs, current medications
fail to control seizures in 20–30% of patients. However, our understanding of the …

[HTML][HTML] Astrocytes as guardians of neuronal excitability: mechanisms underlying epileptogenesis

QP Verhoog, L Holtman, E Aronica… - Frontiers in …, 2020 - frontiersin.org
Astrocytes are key homeostatic regulators in the central nervous system and play important
roles in physiology. After brain damage caused by eg, status epilepticus, traumatic brain …

Neurobiological bases of autism–epilepsy comorbidity: a focus on excitation/inhibition imbalance

Y Bozzi, G Provenzano… - European Journal of …, 2018 - Wiley Online Library
Autism spectrum disorders (ASD) and epilepsy are common neurological diseases of
childhood, with an estimated incidence of approximately 0.5–1% of the worldwide …

NKCC1 chloride importer antagonists attenuate many neurological and psychiatric disorders

Y Ben-Ari - Trends in neurosciences, 2017 - cell.com
In physiological conditions, adult neurons have low intracellular Cl−[(Cl−) I] levels
underlying the γ-aminobutyric acid (GABA) ergic inhibitory drive. In contrast, neurons have …

The WNK-SPAK/OSR1 pathway: master regulator of cation-chloride cotransporters

DR Alessi, J Zhang, A Khanna, T Hochdörfer… - Science …, 2014 - science.org
The WNK-SPAK/OSR1 kinase complex is composed of the kinases WNK (with no lysine)
and SPAK (SPS1-related proline/alanine-rich kinase) or the SPAK homolog OSR1 (oxidative …

Chloride transporters controlling neuronal excitability

JC Pressey, M de Saint-Rome… - Physiological …, 2023 - journals.physiology.org
Synaptic inhibition plays a crucial role in regulating neuronal excitability, which is the
foundation of nervous system function. This inhibition is largely mediated by the …

Seizures and gliomas—towards a single therapeutic approach

G Huberfeld, CJ Vecht - Nature Reviews Neurology, 2016 - nature.com
Epilepsy often develops in patients with glioma, and the two conditions share common
pathogenic mechanisms. Altered expression of glutamate transporters, including the cystine …

[HTML][HTML] Neuronal K+-Cl- cotransporter KCC2 as a promising drug target for epilepsy treatment

E McMoneagle, J Zhou, S Zhang, W Huang… - Acta Pharmacologica …, 2024 - nature.com
Epilepsy is a prevalent neurological disorder characterized by unprovoked seizures. γ-
Aminobutyric acid (GABA) serves as the primary fast inhibitory neurotransmitter in the brain …

An update for epilepsy research and antiepileptic drug development: Toward precise circuit therapy

Y Wang, Z Chen - Pharmacology & therapeutics, 2019 - Elsevier
Epilepsy involves neuronal dysfunction at molecular, cellular, and circuit levels. The
understanding of the mechanism of the epilepsies has advanced greatly in the last three …

[HTML][HTML] Structural basis for inhibition of the Cation-chloride cotransporter NKCC1 by the diuretic drug bumetanide

Y Zhao, K Roy, P Vidossich, L Cancedda… - Nature …, 2022 - nature.com
Cation-chloride cotransporters (CCCs) NKCC1 and NKCC2 catalyze electroneutral symport
of 1 Na+, 1 K+, and 2 Cl− across cell membranes. NKCC1 mediates trans-epithelial Cl …